LifeVantage (LFVN) Form 4: Director granted 13,531 shares at $7.76

Q: What did LifeVantage (LFVN) disclose in this Form 4?

Director Darwin Lewis received an equity grant of 13,531 shares on 11/06/2025 under the outside director compensation program.

Q: What was the reported price for the LFVN director’s grant?

The reported price was $7.76, equal to the weighted average closing price for the ten trading days ending the day before the grant.

Q: When do the newly granted LFVN shares vest?

The shares vest on November 6, 2026, subject to continuous service through that date.

Q: How many LFVN shares does the director own after the transaction?

After the grant, Darwin Lewis beneficially owns 130,748 shares, held directly.

Q: What is the role of the reporting person at LFVN?

The reporting person, Darwin Lewis, is a Director of LifeVantage.

Q: Was this a purchase or a grant under a compensation program?

It was a grant under LifeVantage’s outside director compensation program.

LifeVantage (LFVN) reported a routine insider equity award.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

LifeVantage (LFVN) reported a routine insider equity award. Director Darwin Lewis acquired 13,531 shares of common stock on 11/06/2025 under the company’s outside director compensation program. The price reported was $7.76, defined as the weighted average closing price over the ten trading days ending the day before the grant.

These shares will vest in a single installment on November 6, 2026, contingent on continuous service. Following the grant, Lewis beneficially owns 130,748 shares, held directly.

Insider Trade Summary

Grant/Award: 13,531 shares

Grant/Award 1 txn

Insider Lewis Darwin

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	13,531	$7.76	$105K

Holdings After Transaction: Common Stock — 130,748 shares (Direct)

Footnotes (2)

F1. These shares were granted to the reporting person pursuant to the issuer's outside director compensation program and will vest in a single installment on November 6, 2026, subject to the reporting person's continuous service to the issuer through such date.
F2. The price reported in Column 4 is equal to the weighted average closing price of the issuer's common stock for the ten trading days ending the day before the date of the grant.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did LifeVantage (LFVN) disclose in this Form 4?

Director Darwin Lewis received an equity grant of 13,531 shares on 11/06/2025 under the outside director compensation program.

What was the reported price for the LFVN director’s grant?

The reported price was $7.76, equal to the weighted average closing price for the ten trading days ending the day before the grant.

When do the newly granted LFVN shares vest?

The shares vest on November 6, 2026, subject to continuous service through that date.

How many LFVN shares does the director own after the transaction?

After the grant, Darwin Lewis beneficially owns 130,748 shares, held directly.

What is the role of the reporting person at LFVN?

The reporting person, Darwin Lewis, is a Director of LifeVantage.

Was this a purchase or a grant under a compensation program?

It was a grant under LifeVantage’s outside director compensation program.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 11/10/2025 - 07:14 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lewis Darwin

(Last)

(First)

(Middle)

3300 TRIUMPH BLVD, SUITE 700

(Street)

LEHI

84043

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Lifevantage Corp [ LFVN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/06/2025		A		13,531⁽¹⁾	A	$7.76⁽²⁾	130,748	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. These shares were granted to the reporting person pursuant to the issuer's outside director compensation program and will vest in a single installment on November 6, 2026, subject to the reporting person's continuous service to the issuer through such date.

2. The price reported in Column 4 is equal to the weighted average closing price of the issuer's common stock for the ten trading days ending the day before the date of the grant.

Remarks:

	/s/ Alissa Neufeld, Power of Attorney for Darwin Lewis	11/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR